Fluorizon

Fluorizon is a contract research organisation (CRO) which provides services for the preparation and preclinical evaluation of radiolabeled molecules (radiopharmaceuticals) to international (radio)pharmaceutical companies. Fluorizon’s unique radiolabeling technology allows molecules (e.g. drug candidates) to be rapidly radiolabeled in high yields. Molecular radiolabeling allows customers to gain key insights into how their molecules perform in cellular assays or in small animal models. The data we provide to customers can be used for radiopharmaceutical development and to accelerate drug development pipelines. Fluorizon cooperates exclusively with the Institute of Radiopharmaceutical Cancer Research at the Helmholtz-Zentrum Dresden-Rossendorf and the Department of Radiopharmaceutical and Chemical Biology for PET imaging experiments.